Literature DB >> 420860

Interaction of rat muscle AMP deaminase with myosin. II. Modification of the kinetic and regulatory properties of rat muscle AMP deaminase by myosin.

H Shiraki, H Ogawa, Y Matsuda, H Nakagawa.   

Abstract

The problems of whether the kinetic and regulatory properties of AMP deaminase were modified by formation of a deaminase-myosin complex were investigated with an enzyme preparation from rat skeletal muscle. Results showed that AMP deaminase was activated by binding to myosin. Myosin-bound AMP deaminase showed a sigmoidal activity curve with respect to AMP concentration in the absence of ATP and ADP, but a hyperbolic curve in their presence. Addition of ATP and ADP doubled the V value, but did not affect the Km value. Myosin-bound AMP deaminase also gave a sigmoidal curve in the presence of alkali metal ions, whereas free AMP deaminase gave a hyperbolic curve. GTP abolished the activating effects of both myosin and ATP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 420860     DOI: 10.1016/0005-2744(79)90038-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Influence of exercise on the distribution of enzymes in trout white muscle and kinetic properties of AMP-deaminase from free and bound fractions.

Authors:  V I Lushchak; K B Storey
Journal:  Fish Physiol Biochem       Date:  1994-11       Impact factor: 2.794

2.  AMP deamination and purine exchange in human skeletal muscle during and after intense exercise.

Authors:  Y Hellsten; E A Richter; B Kiens; J Bangsbo
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

3.  Activation of AMP aminohydrolase during skeletal-muscle contraction.

Authors:  Z H Rahim; G Lutaya; J R Griffiths
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

4.  IMP production and energy metabolism during exercise in rats in relation to age.

Authors:  H G Westra; A De Haan; J E van Doorn; E J de Haan
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.